RS64798B1 - Upotreba delgocitiniba za lečenje hroničnog ekcema šaka - Google Patents

Upotreba delgocitiniba za lečenje hroničnog ekcema šaka

Info

Publication number
RS64798B1
RS64798B1 RS20231010A RSP20231010A RS64798B1 RS 64798 B1 RS64798 B1 RS 64798B1 RS 20231010 A RS20231010 A RS 20231010A RS P20231010 A RSP20231010 A RS P20231010A RS 64798 B1 RS64798 B1 RS 64798B1
Authority
RS
Serbia
Prior art keywords
delgocitinib
treatment
hand eczema
chronic hand
chronic
Prior art date
Application number
RS20231010A
Other languages
English (en)
Inventor
Tero Wennberg
Anders Per Sørensen
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of RS64798B1 publication Critical patent/RS64798B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
RS20231010A 2016-01-21 2017-01-20 Upotreba delgocitiniba za lečenje hroničnog ekcema šaka RS64798B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16152215 2016-01-21
EP17701828.0A EP3405197B1 (en) 2016-01-21 2017-01-20 Use of delgocitinib for the treatment of chronic hand eczema
PCT/EP2017/051133 WO2017125523A1 (en) 2016-01-21 2017-01-20 Treatment of hand eczema

Publications (1)

Publication Number Publication Date
RS64798B1 true RS64798B1 (sr) 2023-11-30

Family

ID=55236207

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20231010A RS64798B1 (sr) 2016-01-21 2017-01-20 Upotreba delgocitiniba za lečenje hroničnog ekcema šaka

Country Status (25)

Country Link
US (2) US20200397787A1 (sr)
EP (2) EP4257205A3 (sr)
JP (1) JP6929860B2 (sr)
KR (1) KR20180102662A (sr)
CN (3) CN117159554A (sr)
AU (2) AU2017209932A1 (sr)
BR (1) BR112018014769A2 (sr)
CA (1) CA3010547A1 (sr)
DK (1) DK3405197T3 (sr)
ES (1) ES2963784T3 (sr)
FI (1) FI3405197T3 (sr)
HR (1) HRP20231448T1 (sr)
HU (1) HUE064192T2 (sr)
IL (2) IL297379A (sr)
LT (1) LT3405197T (sr)
MX (2) MX2018008449A (sr)
PL (1) PL3405197T3 (sr)
PT (1) PT3405197T (sr)
RS (1) RS64798B1 (sr)
RU (1) RU2018130097A (sr)
SG (2) SG11201805394QA (sr)
SI (1) SI3405197T1 (sr)
TW (1) TWI783921B (sr)
UA (1) UA123780C2 (sr)
WO (1) WO2017125523A1 (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3968997A1 (en) * 2019-05-15 2022-03-23 Leo Pharma A/S Treatment of cutaneous lupus erythematosus
WO2022167913A1 (en) * 2021-02-02 2022-08-11 Pfizer Inc. Dosing regime for treatment of chronic hand eczema

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
US20130302298A1 (en) * 2010-11-30 2013-11-14 Bio-K Plus International Inc. Treatment and prevention of eczema
US20140343034A1 (en) * 2013-04-25 2014-11-20 Japan Tobacco Inc. Skin barrier function improving agent

Also Published As

Publication number Publication date
JP2019502734A (ja) 2019-01-31
TW201736382A (zh) 2017-10-16
CN117159553A (zh) 2023-12-05
FI3405197T3 (fi) 2023-11-23
LT3405197T (lt) 2023-11-27
TWI783921B (zh) 2022-11-21
PT3405197T (pt) 2023-12-06
RU2018130097A3 (sr) 2020-05-25
IL260094A (en) 2018-07-31
HRP20231448T1 (hr) 2024-03-01
EP4257205A2 (en) 2023-10-11
EP4257205A3 (en) 2023-12-20
PL3405197T3 (pl) 2024-02-12
KR20180102662A (ko) 2018-09-17
SG10202006830WA (en) 2020-08-28
JP6929860B2 (ja) 2021-09-01
CA3010547A1 (en) 2017-07-27
SI3405197T1 (sl) 2024-03-29
US20230138114A1 (en) 2023-05-04
EP3405197A1 (en) 2018-11-28
WO2017125523A1 (en) 2017-07-27
CN117159554A (zh) 2023-12-05
ES2963784T3 (es) 2024-04-02
CN108472297A (zh) 2018-08-31
IL297379A (en) 2022-12-01
BR112018014769A2 (pt) 2018-12-11
HUE064192T2 (hu) 2024-02-28
AU2022252766A1 (en) 2022-11-03
MX2022005915A (es) 2022-06-27
RU2018130097A (ru) 2020-02-21
MX2018008449A (es) 2018-08-09
DK3405197T3 (da) 2023-11-27
UA123780C2 (uk) 2021-06-02
AU2017209932A1 (en) 2018-07-05
TW202332451A (zh) 2023-08-16
SG11201805394QA (en) 2018-08-30
US20200397787A1 (en) 2020-12-24
EP3405197B1 (en) 2023-09-06

Similar Documents

Publication Publication Date Title
HK1247202A1 (zh) 用於治療癌症的化合物
IL259996A (en) Combinations for cancer treatment
PL3122358T3 (pl) Połączenia inhibitorów fgfr i cmet w leczeniu nowotworu
IL311081A (en) Use of pyridofidine to treat functional decline
PL3261726T3 (pl) Kompozycja do leczenia trądziku
HK1258276A1 (zh) 用於治療hiv的化合物和組合
IL248767B (en) Trimethoxyphenyl-benzaimidazole compounds for cancer treatment
PL3377064T3 (pl) Orwepitant do leczenia przewlekłego kaszlu
PT3122349T (pt) Composições para o tratamento da autodigestão
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
EP3440052C0 (en) COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
IL260094A (en) Treatment of hand eczema
IL252493A0 (en) Compounds for use in the prevention or treatment of cancer
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
IL255167A0 (en) Compounds for the treatment of cancer
PL3303486T3 (pl) Kompozycja do obróbki powierzchni
ZA201704589B (en) Compounds for the treatment of cancer
PT3524255T (pt) Composição para o tratamento do acne
GB201511503D0 (en) Finishing treatment